source
- Novo Nordisk seeks injunction to halt Eli Lilly's obesity drug adsNovo Nordisk filed a motion in a New Jersey federal court asking for a preliminary injunction that would stop Eli Lilly's advertisements for its obesity treatments. Novo claims the ads are mislead…
- FDA advisory panel recommends adding peptides BPC-157 and KPV to bulk compounding listAn FDA advisory committee voted 8-6, with one abstention, to recommend that two experimental peptides – BPC-157 for ulcerative colitis and KPV for wound and inflammatory conditions – be placed on t…